ABSTRACT
Diabetic retinopathy (DR) is the leading cause of blindness in people aged 20 to 74 in industrialized nations (1). The vast majority of this blindness (95%) is preventable with the use of routine screening and the application of evidence-based therapy (2). Consequently, ophthalmologic screening in diabetics is absolutely critical.
